Moneycontrol PRO
Upcoming Event:Attend Algo Convention Live, 2 Days & 12+ Speakers at best offer Rs.999/-, exclusive for Moneycontrol Pro subscribers. Register now!

Natco to partner Lupin to market generic breast cancer drug

Hyderabad-based Natco Pharma has filed an abbreviated new drug application with US Food and Drugs Administration for a generic version of Lapatinib Ditosylate tablets of 250 mg strength, used for the treatment of breast cancer. Natco said it has partnered with Lupin to market the product.

June 23, 2011 / 02:11 PM IST
 
 
live
  • bselive
  • nselive
Volume
Todays L/H
More

Moneycontrol Bureau


Hyderabad-based Natco Pharma has filed an abbreviated new drug application with US Food and Drugs Administration for a generic version of Lapatinib Ditosylate tablets of 250 mg strength, used for the treatment of breast cancer. Natco said it has partnered with Lupin to market the product.

Natco



Download your money calendar for 2022-23 here and keep your dates with your moneybox, investments, taxes